Establishment of a humanized SCA2 mouse model carrying a CAA disruption preventing CAG repeat expansion in pathogenic genes

Abstract

Background: Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease marked by significant clinical and genetic heterogeneity, primarily caused by expanded CAG mutations in the ATXN2 gene. The unstable expansion of CAG repeats disrupts the genetic stability of animal models, which is detrimental to disease research.

Methods: In this study, we established a mouse model in which CAG repeats do not undergo microsatellite instability (MSI) across generations. A humanized ATXN2 cDNA with four CAA interruptions within 73 CAG expansions was inserted into the Rosa26 locus of C57BL/6J mice. A 23 CAG control mouse model was also generated to verify ATXN2 integration and expression.

Results: In our model, the number of CAG repeats remained stable during transmission, with no CAG repeat expansion observed in 64 parent-to-offspring transmissions. Compared with SCA2-Q23 mice, SCA2-Q73 mice exhibited progressive motor impairment, reduced Purkinje cell count and volume (indicative of cell atrophy), and muscle atrophy. These observations in the mice suggest that the behavioral and neuropathological phenotypes may reflect the features of SCA2 patients. RNA-seq analysis of the gastrocnemius muscle in SCA2-Q73 mice showed significant changes in muscle differentiation and development gene expression at 56 weeks, with no significant differences at 16 weeks compared to SCA2-Q23 mice. The expression level of the Myf6 gene significantly changed in the muscles of aged mice.

Conclusion: In summary, the establishment of this model not only provides a stable animal model for studying CAG transmission in SCA2 but also indicates that the lack of long-term neural stimulation leads to muscle atrophy.

Keywords

ATXN2 / CAA interruption / genetic stability / mouse model / SCA2

References

[1] Wadia NH, Swami RK. A new form of heredo-familial spinocerebellar degeneration with slow eye movements (nine families). Brain. 1971; 94(2): 359-374.

[2] Babovic-Vuksanovic D, Snow K, Patterson MC, Michels VV. Spinocerebellar ataxia type 2 (SCA2) in an infant with extreme CAG repeat expansion. Am J Med Genet. 1998; 79(5): 383-387.

[3] Velázquez-Pérez L, Medrano-Montero J, Rodríguez-Labrada R, et al. Hereditary ataxias in Cuba: a nationwide epidemiological and clinical study in 1001 patients. Cerebellum. 2020; 19(2): 252-264.

[4] Boesch SM, Müller J, Wenning GK, Poewe W. Cervical dystonia in spinocerebellar ataxia type 2: clinical and polymyographic findings. J Neurol Neurosurg Psychiatry. 2007; 78(5): 520-522.

[5] Reetz K, Rodríguez-Labrada R, Dogan I, et al. Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2. Ann Clin Transl Neurol. 2018; 5(2): 128-137.

[6] Brown AS, Meera P, Altindag B, et al. MTSS1/Src family kinase dysregulation underlies multiple inherited ataxias. Proc Natl Acad Sci USA. 2018; 115(52): E12407-E12416.

[7] Huynh DP, Figueroa K, Hoang N, Pulst SM. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet. 2000; 26(1): 44-50.

[8] Hansen ST, Meera P, Otis TS, Pulst SM. Changes in Purkinje cell firing and gene expression precede behavioral pathology in a mouse model of SCA2. Hum Mol Genet. 2013; 22(2): 271-283.

[9] Aguiar J, Fernández J, Aguilar A, et al. Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice. Neurosci Lett. 2006; 392(3): 202-206.

[10] Damrath E, Heck MV, Gispert S, et al. ATXN2-CAG42 sequesters PABPC1 into insolubility and induces FBXW8 in cerebellum of old ataxic knock-in mice. PLoS Genet. 2012; 8(8): e1002920.

[11] Dansithong W, Paul S, Figueroa KP, et al. Ataxin-2 regulates RGS8 translation in a new BAC-SCA2 transgenic mouse model. PLoS Genet. 2015; 11(4): e1005182.

[12] Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016; 22(11): 1342-1350.

[13] Choudhry S, Mukerji M, Srivastava AK, Jain S, Brahmachari SK. CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms. Hum Mol Genet. 2001; 10(21): 2437-2446.

[14] Wang C, Xu Y, Feng X, et al. Linkage analysis and whole-exome sequencing exclude extra mutations responsible for the parkinsonian phenotype of spinocerebellar ataxia-2. Neurobiol Aging. 2015; 36(1): 545.e1-545.e7.

[15] Gourdon G, Radvanyi F, Lia AS, et al. Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nat Genet. 1997; 15(2): 190-192.

[16] Lloret A, Dragileva E, Teed A, et al. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice. Hum Mol Genet. 2006; 15(12): 2015-2024.

[17] Suzuki K, Sato T, Yamada M, Takahashi H, Tsuji S. DRPLA: recent advances in research using transgenic mouse models. Methods Mol Biol. 2013; 1010: 277-292.

[18] Sen NE, Canet-Pons J, Halbach MV, et al. Generation of an Atxn2-CAG100 knock-in mouse reveals N-acetylaspartate production deficit due to early Nat8l dysregulation. Neurobiol Dis. 2019; 132: 104559.

[19] Sun H, Zhou C, Huang X, et al. Autosomal STRs provide genetic evidence for the hypothesis that tai people originate from southern China. PLoS One. 2013; 8(4): e60822.

[20] Guyenet SJ, Furrer SA, Damian VM, Baughan TD, la Spada AR, Garden GA. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J Vis Exp. 2010; 39: 1787.

[21] Kim D, Paggi JM, Park C, Bennett C, Salzberg SL. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol. 2019; 37(8): 907-915.

[22] Danecek P, Bonfield JK, Liddle J, et al. Twelve years of SAMtools and BCFtools. Gigascience. 2021; 10(2): giab008.

[23] Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovations. 2021; 2(3): 100141.

[24] Cancel G, Durr A, Didierjean O, et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet. 1997; 6(5): 709-715.

[25] Kim JM, Hong S, Kim GP, et al. Importance of low-range CAG expansion and CAA interruption in SCA2 parkinsonism. Arch Neurol. 2007; 64(10): 1510-1518.

[26] Pulst SM, Nechiporuk A, Nechiporuk T, et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet. 1996; 14(3): 269-276.

[27] Shan DE, Liu RS, Sun CM, Lee SJ, Liao KK, Soong BW. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson's disease: clinical implications. Mov Disord. 2004; 19(11): 1357-1360.

[28] Sun H, Satake W, Zhang C, et al. Genetic and clinical analysis in a Chinese parkinsonism-predominant spinocerebellar ataxia type 2 family. J Hum Genet. 2011; 56(4): 330-334.

[29] Tavares de Andrade HM, Cintra VP, de Albuquerque M, et al. Intermediate-length CAG repeat in ATXN2 is associated with increased risk for amyotrophic lateral sclerosis in Brazilian patients. Neurobiol Aging. 2018; 69: 292.e15-292.e18.

[30] Kim A, Park SH, Jeon B. An autopsy case of progressive supranuclear palsy with incidental ATXN2 expansion. JAMA Neurol. 2018; 75(8): 1025-1027.

[31] Lu CS, Wu Chou YH, Kuo PC, Chang HC, Weng YH. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol. 2004; 61(1): 35-38.

[32] Sobczak K, Krzyzosiak WJ. CAG repeats containing CAA interruptions form branched hairpin structures in spinocerebellar ataxia type 2 transcripts. J Biol Chem. 2005; 280(5): 3898-3910.

[33] Xu P, Pan F, Roland C, Sagui C, Weninger K. Dynamics of strand slippage in DNA hairpins formed by CAG repeats: roles of sequence parity and trinucleotide interrupts. Nucleic Acids Res. 2020; 48(5): 2232-2245.

[34] Peel AL, Rao RV, Cottrell BA, Hayden MR, Ellerby LM, Bredesen DE. Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum Mol Genet. 2001; 10(15): 1531-1538.

[35] McLaughlin BA, Spencer C, Eberwine J. CAG trinucleotide RNA repeats interact with RNA-binding proteins. Am J Hum Genet. 1996; 59(3): 561-569.

[36] Davies SW, Turmaine M, Cozens BA, et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell. 1997; 90(3): 537-548.

[37] Igarashi S, Koide R, Shimohata T, et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nat Genet. 1998; 18(2): 111-117.

[38] Laffita-Mesa JM, Paucar M, Svenningsson P. Ataxin-2 gene: a powerful modulator of neurological disorders. Curr Opin Neurol. 2021; 34(4): 578-588.

[39] Scoles DR, Pulst SM. Oligonucleotide therapeutics in neurodegenerative diseases. RNA Biol. 2018; 15(6): 707-714.

[40] Lazure F, Blackburn DM, Corchado AH, et al. Myf6/MRF4 is a myogenic niche regulator required for the maintenance of the muscle stem cell pool. EMBO Rep. 2020; 21(12): e49499.

[41] Kamdar F, das S, Gong W, et al. Stem cell-derived cardiomyocytes and beta-adrenergic receptor blockade in Duchenne muscular dystrophy cardiomyopathy. J Am Coll Cardiol. 2020; 75(10): 1159-1174.

RIGHTS & PERMISSIONS

2025 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.